BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14699425)

  • 1. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
    Sjøholt G; Ebstein RP; Lie RT; Berle JØ; Mallet J; Deleuze JF; Levinson DF; Laurent C; Mujahed M; Bannoura I; Murad I; Molven A; Steen VM
    Mol Psychiatry; 2004 Jun; 9(6):621-9. PubMed ID: 14699425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients.
    Sjøholt G; Gulbrandsen AK; Løvlie R; Berle JO; Molven A; Steen VM
    Mol Psychiatry; 2000 Mar; 5(2):172-80. PubMed ID: 10822345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.
    Ohnishi T; Yamada K; Ohba H; Iwayama Y; Toyota T; Hattori E; Inada T; Kunugi H; Tatsumi M; Ozaki N; Iwata N; Sakamoto K; Iijima Y; Iwata Y; Tsuchiya KJ; Sugihara G; Nanko S; Osumi N; Detera-Wadleigh SD; Kato T; Yoshikawa T
    Neuropsychopharmacology; 2007 Aug; 32(8):1727-37. PubMed ID: 17251911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder.
    Bloch PJ; Weller AE; Doyle GA; Ferraro TN; Berrettini WH; Hodge R; Lohoff FW
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1515-9. PubMed ID: 20800640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral analyses of transgenic mice harboring bipolar disorder candidate genes, IMPA1 and IMPA2.
    Ohnishi T; Watanabe A; Ohba H; Iwayama Y; Maekawa M; Yoshikawa T
    Neurosci Res; 2010 May; 67(1):86-94. PubMed ID: 20153384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures.
    Arai R; Ito K; Ohnishi T; Ohba H; Akasaka R; Bessho Y; Hanawa-Suetsugu K; Yoshikawa T; Shirouzu M; Yokoyama S
    Proteins; 2007 May; 67(3):732-42. PubMed ID: 17340635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
    Dimitrova A; Milanova V; Krastev S; Nikolov I; Toncheva D; Owen MJ; Kirov G
    Pharmacogenomics J; 2005; 5(1):35-41. PubMed ID: 15505643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1.
    Ohnishi T; Ohba H; Seo KC; Im J; Sato Y; Iwayama Y; Furuichi T; Chung SK; Yoshikawa T
    J Biol Chem; 2007 Jan; 282(1):637-46. PubMed ID: 17068342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2).
    Yoshikawa T; Padigaru M; Karkera JD; Sharma M; Berrettini WH; Esterling LE; Detera-Wadleigh SD
    Mol Psychiatry; 2000 Mar; 5(2):165-71. PubMed ID: 10822344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18.
    Nakayama J; Yamamoto N; Hamano K; Iwasaki N; Ohta M; Nakahara S; Matsui A; Noguchi E; Arinami T
    Neurology; 2004 Nov; 63(10):1803-7. PubMed ID: 15557493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of two genes, Impa1 and Impa2 encoding mouse myo-inositol monophosphatases.
    Shamir A; Sjøholt G; Ebstein RP; Agam G; Steen VM
    Gene; 2001 Jun; 271(2):285-91. PubMed ID: 11418250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human myo-inositol monophosphatase 2 rescues the nematode thermotaxis mutant ttx-7 more efficiently than IMPA1: functional and evolutionary considerations of the two mammalian myo-inositol monophosphatase genes.
    Ohnishi T; Tanizawa Y; Watanabe A; Nakamura T; Ohba H; Hirata H; Kaneda C; Iwayama Y; Arimoto T; Watanabe K; Mori I; Yoshikawa T
    J Neurochem; 2013 Mar; 124(5):685-94. PubMed ID: 23205734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium modulation of the human inositol monophosphatase 2 (IMPA2) promoter.
    Seelan RS; Parthasarathy LK; Parthasarathy RN
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1370-8. PubMed ID: 15504365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA).
    Sjøholt G; Molven A; Løvlie R; Wilcox A; Sikela JM; Steen VM
    Genomics; 1997 Oct; 45(1):113-22. PubMed ID: 9339367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples.
    Yoshikawa T; Kikuchi M; Saito K; Watanabe A; Yamada K; Shibuya H; Nankai M; Kurumaji A; Hattori E; Ishiguro H; Shimizu H; Okubo Y; Toru M; Detera-Wadleigh SD
    Mol Psychiatry; 2001 Mar; 6(2):202-10. PubMed ID: 11317223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic structure and sequence analysis of a human inositol polyphosphate 1-phosphatase gene (INPP1).
    Løvlie R; Gulbrandsen AK; Molven A; Steen VM
    Pharmacogenetics; 1999 Aug; 9(4):517-28. PubMed ID: 10780272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder.
    Tomioka Y; Jiménez E; Salagre E; Arias B; Mitjans M; Ruiz V; Sáiz P; García-Portilla MP; de la Fuente L; Gomes-da-Costa SP; Bobes J; Vieta E; Benabarre A; Grande I
    J Affect Disord; 2018 May; 232():229-236. PubMed ID: 29499505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients.
    Jiménez E; Arias B; Mitjans M; Goikolea JM; Roda E; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Oquendo MA; Vieta E; Benabarre A
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1452-62. PubMed ID: 23453640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder.
    Yoshikawa T; Turner G; Esterling LE; Sanders AR; Detera-Wadleigh SD
    Mol Psychiatry; 1997 Sep; 2(5):393-7. PubMed ID: 9322233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder.
    Yoon IS; Li PP; Siu KP; Kennedy JL; Cooke RG; Parikh SV; Warsh JJ
    Mol Psychiatry; 2001 Nov; 6(6):678-83. PubMed ID: 11673796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.